Log In

Forgot Password?

OR

Not a member? Continue as a nonmember.

Become a Member

By becoming a member of the AAN, you can receive exclusive information to help you at every stage of your career. Benefits include:

Join Now See All Benefits

Loading... please wait

2023 Annual Meeting | C12 - Movement Disorders: Huntington's Disease

Saturday 04/22/23
12:15 PM - 02:15 PM EST Add To Calendar
This program will be presented both in-person and online
This program will be available in the meeting's On Demand product.
Seminar
Lauren Seeberger, MD, FAAN
Movement Disorders
Participants should be able to define the clinical characteristics of Huntington's Disease and apply expert advice regarding treatments; understand the basics of genetics in HD and new evidence for age at onset genetic modifiers; and be able to critically evaluate current and anticipated pharmacological and nonpharmacological trials in Huntington's disease.
2.00 CME credits
Patient Care & Procedural Skills, Medical Knowledge
Intermediate
Fellow, Resident, General Neurologist, Advanced Practice Provider, Medical Student
Didactic

Program Materials Program Evaluations

Event Timeline
12:15 PM - 12:45 PM EST Speaker Genetic Determinants: Inheritance and Modifiers in Huntington Disease
Kelly Minks, MS, CGC
12:45 PM - 01:15 PM EST Speaker Motor and Systemic Manifestations of Huntington Disease
Lauren Seeberger, MD, FAAN
01:15 PM - 01:40 PM EST Speaker Neurobehavioral Manifestations of Huntington Disease: Assessment and Management
Ciaran Considine, PhD
01:40 PM - 02:10 PM EST Speaker Research and Development Directions in Huntington Disease
Samuel A. Frank, MD, FAAN
02:10 PM - 02:15 PM EST Discussion Questions and Answers
Lauren Seeberger, MD, FAAN, Samuel A. Frank, MD, FAAN, Ciaran Considine, PhD, Kelly Minks, MS, CGC
Faculty Disclosures
Lauren Seeberger, MD, FAAN Dr. Seeberger has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neurocine Biosciences. Dr. Seeberger has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biohaven. Dr. Seeberger has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neurocrine Biosciences. The institution of Dr. Seeberger has received research support from Neurocrine. The institution of Dr. Seeberger has received research support from TEVA.
Samuel A. Frank, MD, FAAN Dr. Frank has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Frank has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sage Therapeutics. Dr. Frank has received personal compensation in the range of $500-$4,999 for serving as a Consultant for uniQure. The institution of Dr. Frank has received research support from Huntington's Disease Society of America. The institution of Dr. Frank has received research support from Roche/Genentech. The institution of Dr. Frank has received research support from CHDI Foundation. The institution of Dr. Frank has received research support from Huntington Study Group. The institution of Dr. Frank has received research support from Triplet Therapeutics.
Ciaran Considine, PhD Dr. Considine has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for MDisrupt. Dr. Considine has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Park Dietz & Associates. The institution of Dr. Considine has received research support from NIH. The institution of Dr. Considine has received research support from DoD. The institution of Dr. Considine has received research support from Acadia Pharmaceuticals.
Kelly Minks, MS, CGC Kelly Minks, MS, CGC has nothing to disclose.